Table 2 Treatments and outcomes by platelet count category
TP – TP (N = 817) | TP – NTP (N = 666) | NTP – TP (N = 980) | NTP – NTP (N = 4, 987) | P value | |
|---|---|---|---|---|---|
Treatments, (n (%)) | |||||
Mechanical Ventilation | 186 (23) | 232 (35) | 373 (38) | 1037 (21) | < 0.001 |
Use of vasopressors | 76 (9) | 67 (10) | 149 (15) | 254 (5) | < 0.001 |
RBC transfusion | 45 (6) | 37 (6) | 41 (4) | 65 (1) | < 0.001 |
Platelet transfusion | 31 (4) | 14 (2) | 12 (1) | 43 (1) | < 0.001 |
Hypertonic saline | 8 (1) | 16 (2) | 43 (4) | 96 (2) | < 0.001 |
Mannitol | 9 (1) | 10 (2) | 40 (4) | 93 (2) | < 0.001 |
Glucocorticoid | 40 (5) | 26 (4) | 56 (6) | 298 (6) | 0.128 |
Heparin | 31 (4) | 68 (10) | 82 (8) | 379 (8) | < 0.001 |
Outcomes | |||||
ICU mortality, n (%) | 61 (7) | 23 (3) | 87 (9) | 156 (3) | < 0.001 |
Hospital mortality, n (%) | 125 (15) | 42 (6) | 158 (16) | 321 (6) | < 0.001 |
ICU length of stay, d, median, [IQR] | 2 (2, 4) | 4 (2, 8) | 4 (3, 9) | 3 (2, 5) | < 0.001 |
Hospital length of stay, d, median, [IQR] | 6 (4, 9) | 10 (7, 16) | 9 (6, 16) | 6 (4, 10) | < 0.001 |
Hospital discharge location among survivors, n (%) | < 0.001 | ||||
Home | 395 (48) | 239 (36) | 363 (37) | 2546 (51) | |
Rehabilitation | 53 (6) | 105 (16) | 123 (13) | 613 (12) | |
Nursing Home | 4 (0) | 7 (1) | 7 (1) | 24 (0) | |
Skilled Nursing Facility | 140 (17) | 146 (22) | 167 (17) | 809 (16) | |
Other | 100 (12) | 127 (19) | 162 (17) | 674 (14) | |